169 related articles for article (PubMed ID: 26462795)
1. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
Lee JW; Cho A; Yun M; Lee JD; Lyu CJ; Kang WJ
Eur J Radiol; 2015 Dec; 84(12):2633-9. PubMed ID: 26462795
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
Wang G; Si Y; Liu J; Wang W; Yang J
Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
[TBL] [Abstract][Full Text] [Related]
4. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
[TBL] [Abstract][Full Text] [Related]
5. Whole-tumoral metabolic heterogeneity in
Liu J; Ren Q; Xiao H; Li S; Zheng L; Yang X; Feng L; Zhou Z; Wang H; Yang J; Wang W
Cancer Imaging; 2024 Jun; 24(1):72. PubMed ID: 38863073
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
7. High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
Bahri H; Laurence L; Edeline J; Leghzali H; Devillers A; Raoul JL; Cuggia M; Mesbah H; Clement B; Boucher E; Garin E
J Nucl Med; 2014 Nov; 55(11):1786-90. PubMed ID: 25286923
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
Liu YL; Lu MY; Chang HH; Lu CC; Lin DT; Jou ST; Yang YL; Lee YL; Huang SF; Jeng YM; Lee H; Miser JS; Lin KH; Liao YF; Hsu WM; Tzen KY
Oncotarget; 2016 Apr; 7(14):18774-86. PubMed ID: 26959748
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J
Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of
Lee JW; Choi JS; Lyu J; Lee SM
Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
14. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
15. The role of
Lee JW; Seo KH; Kim ES; Lee SM
Eur Radiol; 2017 May; 27(5):1912-1921. PubMed ID: 27590191
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in extensive-stage small cell lung cancer].
Ding CY; Guo Z; Li YY; Li TR
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):828-834. PubMed ID: 29151289
[No Abstract] [Full Text] [Related]
20. [Prognostic Value of Maximum Standard Uptake on Pretreatment ¹⁸F-FDG PET/CT Scan in Newly Diagnosed Follicular Lymphoma].
Ding CY; Sun J; Li TN; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1331-5. PubMed ID: 26524032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
